Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Return on Assets (2016 - 2025)

Cytosorbents' Return on Assets history spans 14 years, with the latest figure at 0.34% for Q4 2025.

  • Quarterly results put Return on Assets at 0.34% for Q4 2025, down 16.0% from a year ago — trailing twelve months through Dec 2025 was 0.34% (down 16.0% YoY), and the annual figure for FY2025 was 0.2%, down 2.0%.
  • Return on Assets for Q4 2025 was 0.34% at Cytosorbents, down from 0.1% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.05% in Q3 2024 to a low of 0.62% in Q3 2022.
  • The 5-year median for Return on Assets is 0.18% (2021), against an average of 0.26%.
  • The sharpest move saw Return on Assets tumbled -45bps in 2022, then surged 51bps in 2024.
  • Year by year, Return on Assets stood at 0.27% in 2021, then plummeted by -97bps to 0.52% in 2022, then skyrocketed by 72bps to 0.15% in 2023, then fell by -27bps to 0.19% in 2024, then plummeted by -84bps to 0.34% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.34%, 0.1%, and 0.09% for Q4 2025, Q3 2025, and Q2 2025 respectively.